• Study on Reducing Lipoprotein Apheresis with Pelacarsen in Patients with High Lipoprotein(a) and Heart Disease in Germany

    Not recruiting

    3 1
    Investigated Drugs:
    Germany

  • Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +6

  • Study of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain

  • Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

    Not recruiting

    2 1 1
    Investigated Drugs:
    Denmark Ireland Poland Spain Sweden

  • Study on Acalabrutinib for Very Old or Frail Patients with Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany

  • Study of Nivolumab, Relatlimab and Bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)

    Not recruiting

    1 1 1
    Investigated Drugs:
    France Germany Italy Poland Spain

  • Study on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study on the Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Croatia Greece Italy Spain

  • Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Estonia Hungary Latvia Lithuania +2

  • Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Spain

powered by